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Presentation of antigen in a suitable form forT cell recognition is required for
the initiation of a primary immune response. Dendritic cells (DC) l purified from
the lymphoid tissues ofmice and rats have been identified as distinctive leukocytes
(1) that have a remarkable ability to stimulate allogeneic T cells in mixed lympho-
cyte reactions (2) and also to present antigen effectively for primary immune re-
sponses (3). The Langerhans' cell in skin (4) and the interdigitating cell (5) found
in the T cell areas oflymph node and tonsil are also considered to be members of
a DC lineage with specialized antigen-presenting properties (1) . Cells with similar
dendritic morphology, which also stain strongly for class II MHC antigens, have
been identified in non-lymphoid tissues (6) and act as a potent stimulus to rejection
of organ allografts (7) .
In man, DC have been described in blood (8, 9) and in the interstitium of non-
lymphoid organs (10) . As in rodents, human DC stimulate allogeneic T cells (8)
and are capable of initiatingprimaryimmune responses (11) . The exact relationship
ofDC, particularly the Langerhans' cell, to cells ofthe monocyte/macrophage lineage
has not been fully resolved . In an attempt to isolate human DC without contamina-
tionby monocytes, we have purifiedDC from tonsils . These cells, which may repre-
sent the interdigitating cells seen in tissue sections, were shown to have a distinctive
morphology similar to that described formouselymphoid DC . This DC population
accounted for the ability of tonsil cells to stimulate T lymphocytes in autologous
and allogeneicMLR . An extensive phenotypic analysis, which included numerous
anti-macrophage mAbs, clearly identified tonsil DC as belonging to a distinct hae-
mopoietic cell lineage.
Materials and Methods
mAbs .
￿
The majority of antibodies used in this study were obtained through the Third
LeucocyteDifferentiation AntigenWorkshop (12). Other antibodies were purchased, or were
gifts of colleagues (see Results and Tables I, II, and III for details) . Positive control staining
for all antibodies was obtained either as part of ourcontribution to the Workshop or by the
use of an appropriate positive cell population .
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Cells.
￿
Tonsils from patients undergoing nonurgent tonsillectomies were collected in sterile
saline within 30min ofremoval . A single cell suspension was prepared by chopping the tissue
finely and passing this material through a sieve. Viable mononuclear cells were obtained by
centrifugation over a Ficoll-Hypaque (FH) 1.077 density gradient (>90% assessed by trypan
blue exclusion) . This cell suspension was depleted ofT cells by rosetting with neuraminidase-
treated SRBC (SRBCN) for 1 .5 h at 4'C . After centrifugation over an FH gradient, the T
cell-depleted (SRBCN - ) fraction was harvested from the FH interface. The T cell (SRBCN)
pellet was also recovered, and the SRBC were removed by hypotonic lysis with NH 4C1 lysis
buffer.
The SRBCN- fraction was resuspended in RPM1 1640 medium containing 10 17o FCS
(Gibco, Auckland, N.Z .), and the cells were cultured in 100-mm plastic petri dishes (Nunc,
Kamstrup, Denmark) for 1-2 d . After culture, the cells were resuspended in 5 ml BSA, d
= 1.082 (Armour Pharmaceutical Co., Kankakee, IL), and overlayed with 2 ml BSA, d =
1.065, and 2 ml RPM1 1640 . The gradients were centrifuged at 1,200 g for 15 min at 4°C,
and the low density (LD), and high density (HD) cells were harvested . For final purification
of DC, the LD cells were labeled with a mixture of BI (CD20), BA1 (CD24), OKT3 (CD3),
and 63D3 antibodies, followed by incubation with fluoresceinated goat anti-mouse Ig (Tago
Inc ., Burlingame, CA). Immunofluorescence double labeling was performed on a sample
from initial preparation at this stage, using either a rhodamine-(CMRF20) or phycoerythrin-
conjugated (Becton Dickinson & Co., Mountain View, CA) mAb toHLA-DR, and viewed
using a Leitz Ortholux microscope with appropriate filters . The labeled LD cells were then
sorted into Bl, BAl, OKT3, and 63D3 positive and negative populations using a FACS (IV;
Becton Dickinson FACS Systems, Sunnyvale, CA) . TheFACS negative population was shown
to contain the DC (see Results) and these DC preparations were used for the subsequent
phenotypic analyses . In >100 preparations to date, only a few tonsils (mainly from adults)
have failed to yield aFACS negative (DC) population, although, in many instances, the prepa-
rations at this stage contained <5% putative DC, and these were not sorted .
MixedLymphocyte Cultures.
￿
Graded doses of mitomycin C-treated (25 wg/ml, 30 min) stimu-
lator cells from the various stages of the purification procedure were added to 2 x 10 5 re-
sponding T cells in 96-well microtest plates (16-3320, Nunc) . The SRBCN+ lymphoid frac-
tion obtained after rosetting was used as the responding cell population and were either
unrelated to the donor (allogeneicMLR) or syngeneic to the donor (autologousMLR) . Cul-
tures were maintained in RPM1 1640 medium supplemented with 10°Jo human AB serum,
2mM glutamine, 100 U/ml penicillin, and 100 wg/ml streptomycin . Proliferation was mea-
sured with a pulse of0.5 pCi of [ 3Hlthymidine (TRA.61, 5 Ci/mmol, Amersham Corp., UK)
at 120-125 h .
Phogocytic Activity.
￿
Latex particles (1.0 u, Sigma Chemical Co., St . Louis, MO) were op-
sonized in human AB serum and incubated with DC for 20 min at 37°C .
Phenotypic Analysis.
￿
Purified DC were analyzed for surface antigen expression using an
extensive panel of antibodies and a sensitive double layer immunoperoxidase technique as
described previously (13) . Staining reactions were graded as definitely positive (+, ++, or
+ + +, according to the intensity ofmembrane staining) or negative (-) compared with the
control, and uncertain weak staining was recorded as t (see Tables in Results) . For in-
tracytoplasmic staining, cytocentrifuge preparations of cells were fixed in methanol for 30
min at 4°C, before application of the appropriate antibody, This was followed by an incuba-
tion with a fluorescein-conjugated anti-Ig reagent, and slides were read using a Leitz Or-
tholux microscope with UV light source .
Cytochemical Staining
￿
Nonspecific esterase staining was performed using a naphthyl-
butyrate as a substrate. Peroxidase and acid phosphatase staining utilized standard cytochemical
techniques .
Morphological Analysis.
￿
For analysis by light microscopy, cytocentrifuge preparations of
purified cells were fixed and stained using May-Grunwald-Giemsa stain. Transmission elec-
tron microscopy was performed on cells after fixation in 2.5 17o glutaraldehyde and post-fixa-
tion in 1% osmium tetroxide. The samples were then stained with uranyl acetate, dehydrated,
and embedded in Spurr's resin .HART AND MCKENZIE
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Results
Purification ofDC
￿
The majority (consistently>95%) ofcells obtained in a single
cell tonsil suspension were CD3 or CD19 positive by FAGS analysis, i.e ., T and
B lymphocytes . Very few 63133 positive cells (monocytes/macrophages)orCD16 posi-
tive (NK) cells were present . After removal ofT cells by rosetting and density gra-
dient centrifugation of the cultured cells, the LD cells obtained were examined by
phase contrast . Most of the cells were large, and many had an irregular profusion
ofmembrane processes as described forDC . However, although FACS analysis re-
vealed that all of these cells stained strongly for HLA-DR antigens, the majority
also stained with CD19, CD20, and anti-Ig reagents, identifying them as B cells .
Further fractionation of the cells was then undertaken by labeling the cells with a
mixture of antibodies directed at T cell, B cell, and monocyte markers, and then
separating positive and negative cells (Fig . 1) . In successful preparations, this proce-
dure revealed aminorLD population, generally 5-20% ofthe cells analyzed, which
were CD3, CD20, CD24, and 63D3 negative, but stained strongly for HLA-DR
antigens . This cell population containing putative DC (-0.1% ofthe starting tonsil
cell suspension) was then subjected to further analysis .
MixedLymphocyte Culture.
￿
As one of the most important characteristics ofDC is
their capacity to stimulate strongly in MLR, each fraction obtained during our
purification procedure was tested for its capacity to stimulate purified T cells . In
allogeneicMLR (Fig. 2 A), the stimulatory capacity was identified in theSRBCN-
fraction, with the SRBCN' fraction containing little or no stimulatory activity. After
culture and density gradient centrifugation, the LD cellular fraction stimulated a
strongT cell-proliferative response, accounting for virtually all the stimulatory ca-
FIGURE 1 .
￿
Double immunofluorescence staining oftonsilDC before furtherFACS IV purifica-
tion . Rhodamine-conjugated anti-HLA-DR mAb(CMRF20) was used to stain cells directly,
and themAbmixture (Bl, BAl, OKT3, and 63133) stained indirectly with fluoresceinated goat
anti-mouseIg. (A) Phase contrast view, putativeDC (arrows); (B)anti-HLA-DR stainsDC strongly
(arrows); (C)DC are negative (arrows) with themAbmixture, but note the larger strongly HLA-
DR' cell (probable B cell) which is stained (') . x40.160
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FIGURE 2. Stimulatory ca-
pacity of isolated DC in MLR.
Graded doses of EN' (A), EN_
u~
￿
(O), LD ("), HD (") tonsil
cells were used to stimulate 2 x
105 allogeneic responding T
i0~
￿
cells (A). After FAGS sorting
FACS-positive (0) or FACS-
negative (/) tonsil cell stimu-
lators were likewise added to
allogeneic T cells (B). In C, au-
tologous T cell responders were
used. Results are expressed as
cpm of tritiated thymidine in-
sTUiOuLATORS x to- 4
￿
corporated.
pacity in isolated tonsil cells. TheHD fraction, on theotherhand, failed to stimulate
allogeneic T cells. Themajor population ofLD cellswere Blymphocytes, with a minor
population ofputative DC. Afterlabeling with CD20, CD24, CD3, and63D3 antibodies,
the positive and negative cell populations isolated by the FACS were tested for their
ability to stimulate in MLR. Theresultsofsuch an experiment comparingthe stimula-
tory activity of the FACS positive cells (B cells) with the FACS negative cells (DC)
is shown in Fig. 2 B. Although the B cell fraction was able to stimulate to a limited
extent, the FACS negative (DC population) had by far the most potent stimulatory
capacity. The LD DC-enriched fraction was also considerably more effective at
stimulating T cells in an autologous MLR (Fig. 2 C).
Morphology ofDC.
￿
FACS-purified DC preparations appeared relatively homoge-
neous (Fig. 3 A and B). The cells were generally considerably larger in size than
unstimulated lymphocytes (15-20 gm) and were of variable shape. There was some
variation in the number of cell membrane protrusions, and a few cells appeared
rounded. Staining the cell membrane with anti-HLA classII reagents was required
to demonstrate the full extent ofthe dendritic processes (Fig. 3 C), andsome ofthese
were particularly long and delicate (Fig. 3 D). The cytoplasm was lightlybasophilic
but less intensely so in the perinuclear region, suggesting a prominent Golgi ap-
paratus. In some preparations, smallvacuoles were noted, butno granules were seen.
The nucleus was large and usually indented with open chromatin and a visible
nucleolus. At an EM level, the cytoplasm was shown to contain numerous mito-
chondria, free ribosomes, little roughendoplasmic reticulum, and alargeGolgi ap-
paratus. No lysozomal structures were identified.
PhagocyticActivity and Cytochemical Staining.
￿
Purified DC did not ingest opsonized
latex particles, whereas control preparations of monocytes and neutrophils did.
Cytochemical staining ofDC wascompared with monocyte/macrophage controlreac-
tions. Some DC were very weakly positive for nonspecific esterase with avery occa-
sional moderately positive cell noted, but these stained much less intensely than
63D3+ cells. The DC were variably positive for acid phosphatase (tartrate sensi-
tive), and this staining was diffuse and confined mainly to the perinuclear region
(no granules were noted) (Fig. 3 E). Peroxidase, PAS, Oil RedO, and 0-glucuronidase
staining was consistently negative.
Phenotypic Analysis with Non-lineage-speck Antibodies.
￿
The DC stained positivelyHART AND MCKENZIE
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FIGURE 3 .
￿
Human tonsil DC . The appearance of MGG-stained FACS-purified cells is shown
in A (x 7.5) and B (x63) . (C) Immunoperoxidase staining with anti-HLA-DR reagent empha-
sises the dendritic processes that are particularly long and delicate in some cells (D). Cytochem-
ical staining with acid phosphastase (E) reveals positive staining adjacent to the nucleus . C, D,
and E, x63 .162
￿
HUMAN TONSIL DENDRITIC CELLS
TABLE I
Reactivity of Non-lineage-specific Antibodies with Isolated DC
Cluster of
' Becton Dickinson & Co ., Mountain View, CA .
with several non-lineage-specific antibodies, as detailed in Table I . Intense staining
wasseen with a variety ofantibodies toMHC class II antigens, including antibodies
specific for HLA-DP, -DQ, and-DR antigens . Although quantitative studies were
not performed, the intensity of staining seen with these three antibodies suggested
that theDC expressedsimilar amountsof the threeMHC class II products . In addi-
tion, the cells expressed class IMHC antigens and reacted with several antibodies
to the leucocytecommon antigen, including antibodies to different epitopes on the
restricted and unrestricted determinants (CD45 and CD45R) .
Several antibodies to the leucocyte function associated (LFA) antigens were tested .
TheDC were positive for CD11a antibodies, recognizing the a chain of LFA-1, and
also, as expected, CD18 antibodies, which recognized the Qchainof theLFA family.
The CDllb and CDllc antibodies, which react with the a chains of otherLEAfamily
molecules, with a somewhat more restricted tissue distribution, were consistently
negative .
Phenotypic Analysis with TandBLymphocyteAntibodies.
￿
The panelofantibodies against
Tand B lymphocyte antigens that were tested on isolated DC, and the results ob-
tained, are shown in Table II . DC lacked virtually all of the well-definedTand B
cell antigens, including those detected by CD1 antibodies, which are known to be
markers for epidermalLangerhans' cells . The onlyT cell antibody that gave significant
staining was the CD4 antibody Leu-3, which gave variable weak labeling of some
DC . The other CD4 antibody used, OKT4, was consistently negative .
Similarly, very fewB cell antibodies stained isolated DC . However, antibodies from
thetwo most recently definedB cell antibody clusters,CD39 andCDw40, were both
positive, as were two unclustered antibodies, 2-7 and7F7 (12) . Examples ofDC stained
using these antibodies with the immunoperoxidase technique are shown in Fig. 4.
TheCD39 reagents showedagradation in staining intensitywith some DC staining
only weakly (Fig . 4C). Intracytoplasmic staining failed to reveal cytoplasmic Ig-M
or IgG, and the nuclei failed to stainfor terminal deoxynucleotide transferase (TdT ;
Bethesda Research Laboratories, Gaithersburg, MD).
differentiation/
specificity mAb
Reactivity
with DC
Source or
reference
HLA-DP HLA-DP + + + BD'
-DQ Leu-10 + + + BD
-DR HLA-DR, DA2 + + + BD, 12
-DQ + DR CMRF-20 + + + This laboratory
HLA-ABC CMRF-6 + This laboratory
CD11a MHM24, CIMT + 12
CDllb OKM1, 44, MOl - 12
CD11c KB23, 3 .9, Ki-Ml, Bu15 - 12
CD18 MHM23, 60 .3 + 12
CD45 CMRF-12, CMRF-26 + + 14
CD45R CMRF-11 + 14
F8.11 .13 + 12HART AND MCKENZIE
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TABLE II
Reactivity of T and B Cell Antibodies with Isolated DC
Cluster of
ATCC, American Type Culture Collection, Rockville, MD ; BD, Becton Dick-
inson & Co ., Mountain View, CA ; C, Coulter Immunology, Hialeah, FL ;
H, Hybritech Inc ., La Jolla, CA .
PhenotypicAnalysis withAntibodies to MyeloidAntigens.
￿
Results obtained witharange
of myeloid antibodies, including the myeloid panel from the Third Leucocyte An-
tigen Workshop, are shown in Table III .
Almost all of the well-defined myeloid antibody clusters, in particular the macro-
phage reactive antibodies, failed to stain isolated tonsil DC . Furthermore the cells
expressed no Fc receptors, as defined by antibody 32 (FcRI) or CDw32(FcRII) and
CD16 (FcRi.) antibodies . DC were also negative with CD35, CD21, and CD11b an-
tibodies, whichrecognizecomplement receptorsCRl (C3b), CRII (C3d), andCRIII
(C3bi), respectively.
Some weak positive staining was obtained with a few antibodies from the myeloid
panel, but none of the antibodies involved were truly myeloid cell specific . Some,
but not all, of the CD13 antibodies stainedDC weakly, butthis positivity was found
to vary from preparation to preparation, and four of the antibodies in this cluster
differentiation/
specificity mAb
Reactivity
with DC
Source' or
reference
CD1 a NAl/34 - 15
b WM-25 - 12
c 7C6/162/3B10 - 12
CD2 OKTII - ATCC
CD3 OKT3 - ATCC
CD4 OKT4 - ATCC
Leu 3 + BD
CD5 UCHT1 - 16
CD7 WTI - 17
HuLyM2 - 18
CD8 OKTS - ATCC
CD9 FMCS - 19
CD10 AL2 - 20
CD19 B4 - C
CD20 B1 - C
CD21 B2 - C
BLIVIOB1 - 12
CD22 HD-39 - 12
CD23 PL-13 - 12
CD24 BA1 - H
CD37 BLIVIOBla - 12
CD39 G28-10, G28-8 + 12
CDw40 G28-5 + 12
B cell subset FMC7 - 21
B cells FMC I - 21
Restricted B + IDC 2-7 + + 12
Restricted B + IDC 7F7 + 12
Plasma cells PCAI - C
Surface Ig SmIg - This laboratory164
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FIGURE 4 .
￿
Immunoperoxidase staining ofpurifiedtonsil DC using a sensitive double-layer im-
munoperoxidase technique . (A)mAb G28.5 (CDw40) is positive (+) . (B) B4 (CD19) is negative
(- ) . (C) mAb G28.8 (CD39) is positive (+) but some cells (arrow) are weakly stained. (D) The
unclustered antibody 2-7 stains DC strongly (++) . x63 .
were consistently negative . The CD13 antibodies, which recognize a carbohydrate
residue, areknown to stain collagen, renal glomeruliand proximal tubules, osteoclasts,
and liver-bile canuliculi (12), in addition to monocytes and granulocytes .
Both antibodies from the CD31 cluster, which detect an antigen found not only
on monocytes, granulocytes, platelets, and some T cells, but also on epithelium and
endothelium (12), stainedDC weakly. One antibody, clustered as CD15c, always gave
astrong positive result, but in ourhands, this antibody wasunusual in that it reacted
with most haemopoietic (and many non-haemopoietic) cells tested .
Some additional antibodies that were not assigned a CD number at the Third
Leucocyte Differentiation Antigen Workshop, namely those in Groups 13, 14, and
15, did show some variable positivity. The staining pattern of these groups of anti-
bodies is known to be widespread and includes endothelium, epithelium, muscle,
monocytes, platelets, and hepatocytes (12).
Staining ofDC with Antibodies to Activation Markers and Other Antigens.
￿
A variety of
mAbs to activation antigens were also tested ; while the CD30 antibodyRSC-1 (Dako
Corp., Santa Barbara, CA) and antibodies to thetransferrin receptor, OKT9, (Amer-
ican Type Culture Collection (ATCC), Rockville, MD), and CMRF2 (this labora-
tory)were negative, several antibodies did give a positive result . The antibodies 4F2
(ATCC) andMMA(ATCC), which are known to reactwith activated cells, stained
DC in a reproducible fashion.HART AND MCKENZIE
TABLE III
Reactivity of Myeloid Cell Antibodies with Isolated DC
BD, Becton Dickinson & Co . ; Dako, Dako Corp., Santa Barbara, CA .
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In addition to the antibodies listed in the tables, a variety ofother antibodies were
also tested fortheir reactivity with DC . An antibody specific for follicularDC, DRC-1
(Dako Corp.) was consistently negative on our DC preparations, as were the NK
cell markers NKH-1 (ATCC) and NKH1 (Coulter Electronics Inc., Hialeah, FL) .
Several antibodies that recognize erythrocyte glycoproteins (24) and an antibody
against human Thy-1 (25) were also negative .
Staining DC with Antibodies to IL-1.
￿
Cytoplasmic staining with the mAbs 13D12
Cluster of
differentiation/
specificity mAb
Reactivity
with DC
Source' or
reference
CD13 My7, WM15, MoU48, MoU28, - 12
SJ-IDI, CLB-mon-gran/2, MCS2 t 12
CD14 a FMC 17, UCHM1 - 12
CD14 6 My4, MEM15, MEM18, Cris6, CLB-mon/1
MA5, TM3, TM2, MoP9, FMC32, MOSI, 12
RM050, 3C10
CD15 a IGIO, VIMD5, MZ17, Thy-22 - 12
CMRF-7 - 13
CD15 b GF.26.7 .3 - 12
CD15 c SYB-8 - 12
8-27-F6 + + 12
CD16 Leulla - BD
BW209/2, CLB/FcR gran 1, MG38 - 12
CD17 T5A7 - 12
CD31 SG134, TM3 t 12
CD32 CIKM5, 2E1 - 12
IV.3 - 22
CD33 My9, LIB2 - 12
CD34 Bl-3C5, My10 - 12
CD35 Cab - Dako
Ell, J3B11, J3D3 - 12
CD36 5F1 - 12
W/S group 9 881-14, G10175 - 12
W/S group 10 20E7, SG133, TE-3A-2C4 - 12
W/S group 11 VIM8 - 12
W/S group 12A 24, Y2/131, KiM6, Y-1/82A, EMB11 - 12
W/S group 12B 10.1, HL21, Ki-M8, Ki-M7 - 12
W/S group 13 MAX-1 - 12
MAX-24 t 12
W/S group 14 8FB t 12
W/S group 15 82H1, MOF11 t 12
W/S group 16 M67 - 12
Follicular DC DRC1 - Dako
Neutrophils LeuM4 - BD
Monocytes LeuM3 - BD
Monocytes 63D3 - 23
FcRI 32 - 22
Erythrocytes CMRF-4, CMRF-10, CMRF-17 - 24166
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and3A4 to IL-1-a and IL -1-R, respectively, was performed (26) . Strong positive in-
tracytoplasmic staining of control LPS-stimulated monocytes was obtained, but no
staining of tonsil DC was seen .
Discussion
The purification procedure described here isolated an LD population ofcells from
human tonsils that were strongly HLA class II positive, had the morphologic ap-
pearance ofDC, and stimulated strongly inMLR. Several studieshave taken advan-
tage of the LD property ofDC to aid in their purification, and murine DC can be
obtained even more readily as a result of their partial adherence to plastic (1) . The
cells obtained from such procedures are often classified asDC on these criteria alone,
but our data would suggest that in man the majority of the LD tonsil cells also ex-
press B cell markers . The fact that human B cells can undoubtedly assume a den-
driticmorphology in culture is notsurprising in view of a recent report (27) drawing
attention to the fact that peripheral blood B cells assumed aDC morphology after
stimulation with thephorbol esterPMA. Clearly, this means that considerable care
is required to characterize humanDC preparations before studying their character-
istics further. The contaminating B cell population in our preparations was found
to stimulate weakly in MLR; in contrast, the minor population of cells that were
negative for theCD24 andCD20 B cell markers were found to be the most potent
stimulators inMLR. This population of cells wasconsistently identified in numerous
tonsil preparations, butthe numbers were small (0.1% ofall tonsil cells) . Some vari-
ation in numbers from different individuals is not unexpected in view of the differ-
ences in interstitial DC content previously noted in different rat strains (7) . It is
also possible that other variables, including the degree of tonsil inflammation,
influenced yields .
TheDC purified from tonsil have a morphological appearance that distinguishes
them from macrophages . The ultrastructural features of these cells are similar to
those described for murine DC (1), and no Birbeck granules typical of Langerhans'
cells were seen . Of note, aprominent Golgi apparatuswasidentified, and this prob-
ably accounts for the acid phosphatase staining noted in these cells . Interestingly,
we did note some minor vacuolation in these cells, and although the cells do not
phagocytose latex particles, further investigation of their ability to take up antigen
is clearly warranted . Since considerable preparation was required to purify the DC,
it is possible that the minordegree ofvacuolation is a degenerative change. Overall,
thefeatures areconsistent with current knowledge ofthe structure ofinterdigitating
cells in tissue sections (5) .
It hasnot yet been possible to assign DC clearly to any of theknown haemopoietic
cell lineages (1, 28), although the Langerhans' cell in the skin expresses the CD1
antigen and has been suggested to have some relationship to the monocyte/macro-
phage lineage, because it has Fc and C3 receptors and phagocytic capability (4).
Although some studies have suggested that theDC belongs to the monocyte/macro-
phage lineage (29, 30), our results do not support this hypothesis . The paucity of
positive reactions obtained with monocyte/macrophage antibodies, the lack of Fc
and complement receptors, and theweak positivity formyeloid relatedenzymesmake
it unlikely that the DC isolated from tonsil belong to this particular cell lineage .HART AND MCKENZIE
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It is also unlikely, given the results we obtained with antibodies to T cell, B cell,
NK cell, anderythrocyte antigens, that theDC arerelated to anyofthese cell lineages .
Thereaction of certain antibodies with the tonsilDC is worthy ofcomment . The
weak reactivity of Leu-3 with these cells is consistent with its reported expression
on interdigitating cells (29, 30) and Langerhans' cells (31), both ofwhich are part
of theDC series . Similarly theCDw40 antibody G28-5 and the antibodies 2-7 and
7F7 that stained tonsil DC have been reported to stain interdigitating cells (32) .
Other antibodies, such as those of the CD13 cluster that were positive, cannot be
interpreted as indicating lineage specificity as they react with awide range ofdifferent
cell types (12) . TheCD39 antibodies, forinstance, are positive on B cells, activated
T cells, monocytes, macrophages, and blood vessel endothelium . Even so, it is
noteworthy that some ofthese nonlineage specific antibodies also react with Langer-
hans' cells in the skin (33) . Overall, it would seem then that the human DC stems
from aunique differentiation pathway, whichone couldpostulate mayincludeLanger-
hans' cells, lymphoid DC, interdigitating cells, and interstitial DC . Indeed, an ex-
tensive set of morphological, phenotypic, and functional comparisons of murine
epidermal Langerhans' cellswith spleenDC hasrecently been describedby Schuler
et al . (34) . These studies showed that isolated murine Langerhans' cells, whichwere
NSE, ATPase, F4180 (anti-macrophage), and2AG2 (anti-Fc receptor) positive, lost
these characteristicsandbecame better stimulators o£T cells in culture, i.e ., similar
to spleenDC, andtheauthors suggested that Langerhans' cellswereDC precursors .
The modulation of F,, receptors is particularly interesting, as we have noted that
human Langerhans' cells in skin, like tonsil DC, fail to stain with mAbs to FcR1,
F,RII, and F,RIII .
The DC we obtained did express HLA.ABC and HLA.DP, DQ, and DR an-
tigens, as well as oneoftheleucocyte function-associated antigens(LFA1) . It is remark-
able how few other molecules have so far been detected on the cell surface ofDC,
especially when one considers how many different antigens are detected on other
cell types . To date, cell membrane analysis has failed to reveal a specific marker for
humanDC analogous to the antigen on mouseDC (35) . We have noticed that anti-
HLA-DQreagents do stain DC somewhat more selectivelythan anti-HLA-DR re-
agents, thereby resulting in apparent specificity for DC that express HLA-DQ in
high density relative to other cell types. This may explain the results reported using
the antibody RFD-1 (36) .
The expression of certain potential activation antigens (MMA, 4F2) on the iso-
latedDC wasof interest. It is uncertain whether this was induced during theculture
period, as described for inflammatory macrophages and IL-2-R (37), or whether
resting DC express these antigens . Initial studies on the expression of IL-2-R on
isolatedDC have given conflicting results, although staining skin (Davis et al., sub-
mitted for publication) and liver (Prickett et al ., submitted forpublication) sections
fails to reveal IL-2-R onDC . The recent description ofhigh- andlow-affinity receptors
for IL-2 (38)makes it appropriate forus to investigate the effect ofIL-2onDC function.
Although many otherMHC class II positive cell types are capable of presenting
antigen in a secondary immune response, theDC family seems to be unique in its
capacity to stimulate a primary response (39) . The reasons for this are unclear. Al-
though this may be a consequenceofhigh density class IIMHC antigen expression
in combination with multiple membrane contacts with the interactingT cells, it is168
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possiblethatDC may possesslineage specific, asyet undetected membrane molecules
or lymphokines, which are responsible for this unique function. Our inability to
demonstrate IL-la or IL-1R in these cells increases ourenthusiasm in the search for
such molecules. However, we wish to emphasise that an irregular cell membrane
and MHC class II antigen positivity does not necessarily identify a DC, and we
would stress thatprogress in analyzinghumanDCwill only result from investigating
highly purified populations shown on the basis of Tcell stimulation and surface
marker studies to be homogeneous cell populations.
Summary
Human dendritic cells were isolated from tonsils by density gradient separation
followed by FAGS IV sortingwith mAbs to remove contaminating cell populations.
Theresultingdendritic cellpopulation consistedoflargecellswith plentifulbasophilic
cytoplasm, lacking in granules but containing a prominent Golgi apparatus and
numerous mitochondria. The cell membrane wasirregular, and marked cellprotru-
sionswere obviouswhen stained withanti-HLAclass II reagents. Theirnuclei were
irregular and often indented with a visible nucleolus. These cells were not phago-
cytic and stimulated autologous and allogeneic lymphocytes more effectively than
other tonsil cell types in MLR. Phenotypic analysis ofthese cells confirmed that
they expressed the leucocyte common antigen and stained strongly for HLA-class
II antigens. Tonsil dendritic cells also coexpressed the LFA-la and LFA-10 chains
but did not stain with a wide variety of anti-monocyte or anti-macrophage anti-
bodies. The cells also lacked Fc and complement receptors and failed to stain with
CDl antibodes. Extensive testingwith mAbs revealed only a few positive reactions,
and these were consistent with reports of these antibodies staining interdigitating
cells in tissue sections. This established that tonsil dendriticcells belong to theunique
haemopoietic celllineage ofdendritic cells. No cytoplasmicstaining ofIL-la or IL-
10 was demonstrated, although these lymphokineswere readily detected in activated
monocytes.
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